In recent years, some clinicians have explored starting GLP-1 therapy at very small doses — a process often described as “microdosing.” The idea isn’t about taking less medicine overall, but rather allowing the body to adjust slowly while minimizing discomfort.
This gradual introduction can be appealing for those who are sensitive to new treatments or simply want a gentler experience. Still, microdosing should always be approached carefully, guided by a licensed medical provider.
Traditional GLP-1 programs use a structured dosing schedule, stepping up in consistent increments. In contrast, microdosing begins far below the standard entry point — sometimes as little as one-tenth of the usual first dose.
The theory is simple: smaller beginnings may give your digestive system and metabolism time to adapt, potentially reducing nausea, fatigue, or other side effects that can occur early on. For some, this helps build confidence and consistency during the first phase of therapy.
A typical microdosing plan might look like this:
Unlike traditional dosing — where adjustments may follow a set timeline — microdosing is entirely individualized. The emphasis is on how your body responds, not on hitting a specific number.
In the early phase, you may notice:
If symptoms feel uncomfortable, it’s often possible to pause at the current level until things stabilize. In most cases, small adjustments — rather than big jumps — make the process smoother.
Microdosing doesn’t guarantee stronger or faster results. For many, it’s simply a gentler path that helps the body and mind ease into therapy with fewer setbacks. If the lower range provides benefits without discomfort, your clinician may recommend staying there; if not, they can guide you through a transition to standard dosing safely.
At Easylose, we see microdosing as one more way to tailor care to the individual — never a one-size-fits-all solution, but a mindful, measured approach that honors your pace.
Explore our collection of 200+ Premium Webflow Templates